Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation

Keiichi Akaiwa1, Hidetoshi Akashi, Hideki Harada

  • 1Department of Surgery, Kurume University School of Medicine, Kurume, Japan.

Brain Research
|October 28, 2006
PubMed

Insights

Cerebral venous congestion (VC) before stroke significantly reduced brain infarct size and neurological deficits in rats. Mild VC provided neuroprotection, while severe VC increased mortality, suggesting a therapeutic window for adenosine A1 receptor activation.

Area of Science:

  • Neuroscience
  • Cardiovascular Surgery
  • Cerebrovascular Research

Background:

  • Stroke is a major complication in cardiovascular surgery, often exacerbated by increased intracranial pressure due to cerebral venous circulatory disturbances (CVCD).
  • Previous research indicated that inducing CVCD before cerebral ischemia could decrease infarct area.

Purpose of the Study:

  • To investigate the neuroprotective effects of pre-ischemic cerebral venous congestion (VC) in a rat model of focal cerebral ischemia.
  • To evaluate the role of adenosine A1 receptor activation in mediating this protective effect.

Main Methods:

  • Focal cerebral ischemia was induced in spontaneously hypertensive rats using filament insertion.
  • Rats were assigned to sham-operated, mild VC, severe VC, or DPCPX (adenosine A1 receptor antagonist) groups.
  • Evaluated infarct volume, cerebral edema, S-100 protein levels, and behavioral deficits.

Main Results:

  • Mild and severe VC groups exhibited significantly reduced infarct volumes compared to sham and DPCPX groups.
  • Mild VC significantly decreased edema and neurological deficits compared to other groups.
  • Severe VC led to a time-dependent increase in mortality.
  • DPCPX administration abolished the protective effects of mild VC.

Conclusions:

  • Appropriate pre-ischemic cerebral venous congestion can rapidly induce cerebral protection, likely mediated by adenosine A1 receptor activation.
  • Mild VC demonstrates neuroprotective potential, reducing infarct size, edema, and neurological deficits.
  • The findings suggest a potential therapeutic strategy for stroke prevention or treatment by modulating cerebral venous pressure.

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...